BROADWOOD CAPITAL INC
CIK 1278387 · last filed 2026-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
STAA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
3RD FLOOR
NEW YORK, NY 10019
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | 10%+ Owner | 12,685,041 | $3.20 | $40.59M | $75.10M | 7 | 2026-04-27 |
| STAA | 10%+ Owner | 26,526,474 | $23.68 | $628.15M | $62.94M | 37 | 2025-04-07 |
| LCTX | 10%+ Owner | 68,730,970 | $1.02 | $70.45M | $4.03M | 2 | 2022-03-25 |
| BTX | 10%+ Owner | — | $8.69 | — | $0 | 2 | 2017-09-13 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | 10%+ Owner | 27,182,162 | — | — | $46.04M | 10 | 2017-02-17 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | 1,282,050 | — | — | $0 | 1 | 2015-02-11 | |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 3,636,496 | — | — | -$92.74M | 4 | 2014-08-06 |
| PALOMAR MEDICAL TECHNOLOGIES LLC (PMTI) Delisted | 10%+ Owner | 5,617,246 | — | — | $3.75M | 3 | 2012-06-28 |
| COMARCO INC (CMRO) Delisted | 10%+ Owner | 3,051,668 | — | — | $2.35M | 7 | 2008-04-29 |
Recent Filings · Page 6 of 8
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-06-05 | PALOMAR MEDICAL TECHNOLOGIES LLC (PMTI) Delisted | Buy (P) | +28,800 | $230.0K | EDGAR |
| 2012-05-23 | PALOMAR MEDICAL TECHNOLOGIES LLC (PMTI) Delisted | Buy (P) | +183,600 | $1.53M | EDGAR |
| 2010-09-10 | STAA | Buy (P) | +85,779 | $374.8K | EDGAR |
| 2010-05-11 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Exer (X) | +6,600,000 | $12.01M | EDGAR |
| 2009-06-18 | STAA | Buy (P) | +3,478,086 | $6.54M | EDGAR |
| 2008-04-29 | COMARCO INC (CMRO) Delisted | Buy (P) | +88,500 | $318.4K | EDGAR |
| 2008-04-21 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Other (J) | −330,000 | $0 | EDGAR |
| 2008-04-18 | COMARCO INC (CMRO) Delisted | Buy (P) | +353,100 | $1.18M | EDGAR |
| 2008-02-14 | STAA | Buy (P) | +23,400 | $49.1K | EDGAR |
| 2008-01-24 | STAA | Buy (P) | +428,376 | $929.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.